Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Group K Diagnostics We can highlight the next thriving fund investment areas, such as Health Diagnostics, Pharmaceutical.
The usual cause for the fund is to invest in rounds with 1 partaker. Despite the FHA Holdings, startups are often financed by BioAdvance.
When the investment is from FHA Holdings the average startup value is 1-5 millions dollars. Deals in the range of 100 thousands - 1 million dollars are the general things for fund. The fund is constantly included in less than 2 deals per year. The high activity for fund was in 2018.
Related Funds
| Fund Name | Location |
| Amplio Ventures | Atlanta, Georgia, United States |
| Cahill Goron &Reindel | New York, New York, United States |
| Carbon Arrow | - |
| China Aerospace Investment Holdings | Beijing, Beijing, China |
| China Southern Media | - |
| DG Daiwa Ventures | Chiyoda, Japan |
| Eisenhower Fellowships | Pennsylvania, Philadelphia, United States |
| Jinhua Jiujiu | - |
| Red Cell Partners | - |
| Ze.Flor | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Group K Diagnostics | $437K | 01 Aug 2018 | Philadelphia, Pennsylvania, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Group K Diagnostics | $437K | 01 Aug 2018 | Philadelphia, Pennsylvania, United States |
